Clinical Trials
10 trialsNCT00452439 2020-12-28
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00089661 2018-10-17
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Amgen
Phase 3 Completed
NCT00980174 2018-10-17
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Phase 3 Completed
NCT00824993 2018-09-13
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT00050011 2014-03-21
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Novartis
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00859703 2013-10-31
RISAROS
Hospices Civils de Lyon
Phase 3 Completed
NCT00352846 2013-07-02
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00171340 2012-04-16
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Novartis
Phase 3 Completed